| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1006382775 |
| P356 | DOI | 10.1007/S002800051031 |
| P698 | PubMed publication ID | 8765410 |
| P2093 | author name string | Brunda MJ | |
| Wigginton JM | |||
| Wiltrout RH | |||
| Palleroni AV | |||
| Wright RB | |||
| Hendrzak JA | |||
| Luistro L | |||
| Aglione A | |||
| Dvorozniak M | |||
| Rumennik L | |||
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | S16-21 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | Antitumor activity of interleukin 12 in preclinical models | |
| P478 | volume | 38 Suppl |
| Q48035556 | A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Eastern Cooperative Oncology Group study E1E96. |
| Q45881194 | Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma |
| Q45753016 | Cytokine mRNA expression in whole blood samples from dogs with natural canine distemper virus infection |
| Q41027728 | Cytokine sensitivity of metastatic human melanoma cell lines-- simultaneous inhibition of proliferation and enhancement of gelatinase activity |
| Q50158545 | Development and Applications of Patient-Derived Xenograft Models in Humanized Mice for Oncology and Immune-Oncology Drug Discovery |
| Q47751137 | Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin |
| Q40464370 | Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12. |
| Q30416228 | Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study |
| Q77903163 | General classes and functions of four-helix bundle cytokines |
| Q37315226 | Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow |
| Q37457553 | Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12. |
| Q90589027 | MicroRNA binding site polymorphism in inflammatory genes associated with colorectal cancer: literature review and bioinformatics analysis |
| Q40628176 | Mullerian Inhibiting Substance Promotes Interferon γ-induced Gene Expression and Apoptosis in Breast Cancer Cells |
| Q61819244 | Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model |
| Q38059773 | Plasmid IL-12 electroporation in melanoma. |
| Q40559621 | Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine |
| Q73075642 | Sustained-release interleukin-12 microspheres in the treatment of cancer |
| Q44086025 | Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL). |
| Q41547351 | The biochemistry of cancer dissemination |
| Q33657643 | The toxicology of interleukin-12: a review |
Search more.